Ignite Creation Date:
2024-05-05 @ 11:07 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00002373
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-11-02
Brief Title:
The Safety and Effectiveness of Different Dose Levels of 1263W94 in the Treatment of Cytomegalovirus CMV of the Eyes in HIV-Infected Patients
Sponsor:
Glaxo Wellcome
Organization:
NIH AIDS Clinical Trials Information Service
Organization Data
Organization:
NIH AIDS Clinical Trials Information Service
Class:
INDUSTRY
Study ID:
263A
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Glaxo Wellcome
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None